The BRCA1 c. 5096G > A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium

S Moghadasi, H D Meeks, MPG Vreeswijk, LAM Janssen, A Borg, H Ehrencrona, Y Paulsson-Karlsson, B Wappenschmidt, C Engel, A Gehrig, N Arnold, TV Hansen, Marga Thomassen, UB Jensen, TA Kruse, B Ejlertsen, AM Gerdes, IS Pedersen, SM Caputo, F CouchEJ Hallberg, Ans van den Ouweland, Margriet Collee, E Teugels, MA Adank, RB van der Luijt, AR Mensenkamp, JC Oosterwijk, MJ Blok, N Janin, KBM Claes, K Tucker, V Viassolo, AE Toland, DE Eccles, P Devilee, CJ van Asperen, AB Spurdle, DE Goldgar, EG Garcia

Research output: Contribution to journalArticleAcademicpeer-review

51 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)15-20
Number of pages6
JournalJournal of Medical Genetics
Volume55
Issue number1
DOIs
Publication statusPublished - 2018

Research programs

  • EMC OR-01

Cite this